ADC	Antibody-drug conjugate
ALK	Anaplastic lymphoma kinase
AREG	Amphiregulin
ATS	American Thoracic Society
BBB	Blood–brain barrier
BTC	Betacellulin
CRC	Colorectal Cancer
CAF	Cancer associated fibroblasts
CTC	Circulating tumor cells
ECD	Extracellular domain
EGF	Epidermal growth factor
EGFR	Epidermal growth factor receptor
EPGN	Epigen
EREG	Epiregulin
ERS	European Respiratory Society
ESCC	Esophageal squamous cell carcinoma
FGFR	Fibroblast growth factor receptor
FGFR3	Fibroblast growth factor receptor 3
GAB1	GRB2 associated binding protein 1
GRB2	Growth factor bound protein 2
HB-EGF	Heparin-binding EGF-like growth factor
HER2	Human epidermal growth factor receptor 2
HER3	Human epidermal growth factor receptor 3
HER3-DXd	Patritumab Deruxtican
HER4	Human epidermal growth factor receptor 4
HNSCC	Head and neck squamous cell carcinoma
IALSC	International Association for the Study of Lung Cancer
IgG1	Immunoglobulin G1
mAb	Monoclonal antibody
MET	Mesenchymal epithelial transition
MIBC	Muscle-invasive bladder cancer
mUC	Metastatic urethral carcinoma
NMIBC	Non-muscle Invasive bladder cancer
NSCLC	Non-small cell lung cancer
NRG/NRG1	Neuregulin
OS	Overall survival
PFS	Progression-free survival
RFS	Relapse-free survival
RTK	Receptor tyrosine kinase
RECIST	Response evaluation criteria in solid tumors
SHC	Src homology and collagen
TGFα	Transforming growth factor alpha
TKI	Tyrosine kinase inhibitor
TNBC	Triple negative breast cancer
Trop-2	Human trophoblast cell-surface antigen 2
TURBT	Transurethral resection of bladder tumor